X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (137) 137
Publication (7) 7
Book Review (4) 4
Book / eBook (1) 1
Book Chapter (1) 1
Conference Proceeding (1) 1
Music Score (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (61) 61
female (35) 35
middle aged (31) 31
adult (30) 30
oncology (30) 30
male (29) 29
aged (24) 24
hematology, oncology and palliative medicine (20) 20
pulmonary/respiratory (15) 15
animals (13) 13
lung cancer (13) 13
index medicus (12) 12
chemotherapy (11) 11
lung neoplasms - drug therapy (10) 10
cancer (9) 9
treatment outcome (9) 9
adolescent (8) 8
carcinoma, small cell - drug therapy (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
carcinoma (7) 7
colony-stimulating factor (7) 7
gastrin-releasing peptide (7) 7
mice (7) 7
antineoplastic agents - therapeutic use (6) 6
etoposide - administration & dosage (6) 6
lung neoplasms - pathology (6) 6
prognosis (6) 6
research (6) 6
analysis (5) 5
article (5) 5
carcinoma, small cell - pathology (5) 5
children (5) 5
colony-forming units assay (5) 5
expression (5) 5
growth (5) 5
hematopoietic stem cell transplantation (5) 5
lung cancer, non-small cell (5) 5
lung neoplasms - genetics (5) 5
lung neoplasms - mortality (5) 5
lung neoplasms - therapy (5) 5
medicine, general & internal (5) 5
studies (5) 5
aged, 80 and over (4) 4
bone neoplasms - drug therapy (4) 4
bone neoplasms - secondary (4) 4
carboplatin - administration & dosage (4) 4
carcinoma, small cell - metabolism (4) 4
carcinoma, small cell - mortality (4) 4
cells, cultured (4) 4
chemistry, physical (4) 4
clinical trials (4) 4
combined modality therapy (4) 4
diphosphonates - therapeutic use (4) 4
dose-response relationship, drug (4) 4
hematology (4) 4
lung neoplasms - metabolism (4) 4
lymphoma, non-hodgkin - therapy (4) 4
oncology, experimental (4) 4
quality of life (4) 4
receptors, bombesin (4) 4
recombinant proteins (4) 4
risk factors (4) 4
sarcoma - drug therapy (4) 4
smoking (4) 4
survival rate (4) 4
united kingdom (4) 4
adolescents (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
association (3) 3
bombesin - metabolism (3) 3
breast cancer (3) 3
carboplatin (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
carcinoma, non-small-cell lung - metabolism (3) 3
case-control studies (3) 3
cells (3) 3
combination (3) 3
cyclophosphamide - administration & dosage (3) 3
deafness (3) 3
double-blind (3) 3
energy-loss spectroscopy (3) 3
etoposide (3) 3
family health (3) 3
genomes (3) 3
granulocyte colony-stimulating factor - therapeutic use (3) 3
growth substances - physiology (3) 3
ifosfamide - administration & dosage (3) 3
infusions, intravenous (3) 3
leukemia (3) 3
lung neoplasms - blood (3) 3
medicine (3) 3
multiple-myeloma (3) 3
neoplasms (3) 3
neoplasms - therapy (3) 3
neuropeptides - physiology (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Jiang, X and Finucane, Hilary K and Schumacher, Freick R and Schmit, S.L and Tyrer, J.P and Han, Y and Michailidou, Kyriaki and Lesseur, C and Kuchenbaecker, Karoline and Dennis, Joe and Conti, Giario and Casey, Graham and Gaudet, M.M and Huyghe, Jeroen R and Albanes, Demetrius and Alich, Melinda and Anew, A.S and Anulis, I.L and Anton-Culver, Hoda and Antoniou, A.C and Antonenkova, N.N and Arnold, S.M and Aronson, K.J and Arun, Banu and Bandera, Elisa and Barkardottir, R.B and Barnes, Daniel and Batra, J and Beckmann, Matthias and Benítez, Javier and Benlloch, Sara and Berchuck, Anew and Berndt, Sonja and Bickeböller, Heike and Bien, S.A and Blomqvist, Carl and Boccia, Stefania and Bogdanova, N.V and Bojesen, Stig and Bolla, M.K and Brauch, Hiltrud and Brenner, H and Brenton, J.D and Brook, R.H and Brunet, Joan and Brunnström, H and Buchanan, D.D and Burwinkel, Barbara and Butzow, Ralf and Cadoni, Gabriella and Caldes, Trinidad and Caligo, M.A and Campbell, Ian and Campbell, P.T and Cancel-Tassin, G and Cannon-Albright, Lisa and Campa, Daniele and Caporaso, Neil and Carvalho, A.L and Chan, A.T and Chang-Claude, Jenny and Chanock, Stephen and Chen, C and Christiani, D.C and Claes, K.B.M and Claessens, F and Clements, J and Collée, J.M and Correa, M.C and Couch, Fergus and Cox, Angela and Cunningham, Julie and Cybulski, Cezary and Czene, Kamila and Daly, Mary and DeFazio, Anna and Devilee, Peter and Diez, O and Gago-Dominguez, Manuela and Donovan, J.L and Dörk, T and Duell, Eric and Dunning, A.M and Dwek, M and Eccles, Diana and Edlund, Christopher and Edwards, D.R.V and Ellberg, C and Evans, D.G and Fasching, Peter and Ferris, R.L and Liloglou, T and Figueiredo, J.C and Fletcher, Olivia and Fortner, R.T and Fostira, F and Franceschi, S and Friedman, Eitan and Gallinger, Steve and Ganz, Patricia and ...
Nature Communications, ISSN 2041-1723, 09/2019, Volume 10, Issue 1
textabstractAn amendment to this paper has been published and can be accessed via a link at the top of the paper. 
Journal Article
by McKay, J.D and Hung, R.J and Han, Y and Zong, X and Carreras-Torres, R and Christiani, D.C and Caporaso, N and Johansson, M and Li, Y and Byun, J.Y and Dunning, A and Pooley, K.A and Qian, D.C and Liu, G and Bojesen, S.E and Wu, X and Marchand, L. le and Albanes, D and Bickeböller, H and Alich, M.C and Bush, W.S and Tardon, A and Rennert, G and Teare, M.D and Field, J.K and Kiemeney, L.A and Lazarus, P and Haugen, A and Schabath, M.B and Anew, A.S and Shen, H and Hong, Y.C and Yuan, J.M and Bertazzi, P.A and Pesatori, A.C and Ye, Y and Diao, N and Su, L and Zhang, R and Brhane, Y and Leighl, N and Johansen, J.S and Mellemgaard, A and Saliba, W and Haiman, C.A and Wilkens, L.R and Fernandez-Somoano, A and Fernandez-Tardon, G and Heijden, H.F.M. van der and Kim, J.H and Hu, Z and Davies, M and Brunnström, H and Manjer, J and Melander, O and Muller, D and Overvad, K and Trichopoulou, A and Tumino, R and Doherty, J.A and Barnett, M.P and Chen, C and Goodman, G.E and Cox, A and Taylor, F and Woll, P.J and Brüske, I and Wichmann, H.E and Manz, J and Muley, T.R and Risch, A and Rosenberger, A and Grankvist, K and Shepherd, F.A and Tsao, M.S and Haura, E.B and Bolca, C and Holcatova, I and Janout, V and Kontic, M and Lissowska, J and Mukeria, A and Ognjanovic, S and Orlowski, T.M and Scelo, G and Swiatkowska, B and Zaridze, D and Bakke, P and Skaug, V and Zienolddiny, S and Duell, E.J and Butler, L.M and Koh, W.P and Gao, Y.T and Houlston, R.S and McLaughlin, J and Stevens, V.L and Joubert, P and Lamontagne, M and Nickle, D.C and ... and SpiroMeta Consortium and Medicinska fakulteten and Institutionen för medicinsk biovetenskap and Institutionen för strålningsvetenskaper and Umeå universitet
Nature Genetics, ISSN 1061-4036, 2017, Volume 49, Issue 7, pp. 1126 - 1132
Journal Article
Lung Cancer, ISSN 0169-5002, 2013, Volume 79, pp. S34 - S34
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 47, pp. S665 - S665
Journal Article
Journal Article
Lung Cancer, ISSN 0169-5002, 2010, Volume 67, pp. S5 - S6
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2012, Volume 48, Issue 13, pp. 1957 - 1968
Journal Article
British Journal of Cancer, ISSN 0007-0920, 03/2012, Volume 106, Issue 6, pp. 1153 - 1159
BACKGROUND: Thalidomide has potent anti-inflammatory and anti-angiogenic properties. It was evaluated in combination with chemotherapy in two randomised... 
lung cancer | thalidomide | biomarker | angiogenesis | MULTIPLE-MYELOMA | CARBOPLATIN | BEVACIZUMAB | MARKERS | COMBINATION | VASCULAR ENDOTHELIAL GROWTH | THERAPY | ONCOLOGY | DOUBLE-BLIND | RECEPTOR-2 | PROGRESSION | Neovascularization, Pathologic - mortality | Lung Neoplasms - drug therapy | Multivariate Analysis | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Small Cell Lung Carcinoma - drug therapy | Neovascularization, Pathologic - blood | Small Cell Lung Carcinoma - blood | Clinical Trials, Phase III as Topic | Multicenter Studies as Topic | Angiogenesis Inhibitors - therapeutic use | Female | Intercellular Adhesion Molecule-1 - blood | Interleukin-8 - blood | Deoxycytidine - administration & dosage | Proportional Hazards Models | Vascular Endothelial Growth Factor A - blood | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Fibroblast Growth Factor 2 - blood | Carcinoma, Non-Small-Cell Lung - mortality | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Survival Analysis | Carcinoma, Non-Small-Cell Lung - blood | Small Cell Lung Carcinoma - mortality | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | Thalidomide - therapeutic use | Deoxycytidine - analogs & derivatives | Molecular Diagnostics
Journal Article